1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Injectable Anticoagulants Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Low-Molecular-Weight Heparin (LMWH) 1.2.3 Direct Thrombin Inhibitor (DTI) 1.2.4 Others 1.3 Market by Application 1.3.1 Global Injectable Anticoagulants Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 VTE 1.3.3 ACS/MI 1.3.4 AF 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Injectable Anticoagulants Market Perspective (2016-2027) 2.2 Injectable Anticoagulants Growth Trends by Regions 2.2.1 Injectable Anticoagulants Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Injectable Anticoagulants Historic Market Share by Regions (2016-2021) 2.2.3 Injectable Anticoagulants Forecasted Market Size by Regions (2022-2027) 2.3 Injectable Anticoagulants Industry Dynamic 2.3.1 Injectable Anticoagulants Market Trends 2.3.2 Injectable Anticoagulants Market Drivers 2.3.3 Injectable Anticoagulants Market Challenges 2.3.4 Injectable Anticoagulants Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Injectable Anticoagulants Players by Revenue 3.1.1 Global Top Injectable Anticoagulants Players by Revenue (2016-2021) 3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2016-2021) 3.2 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Injectable Anticoagulants Revenue 3.4 Global Injectable Anticoagulants Market Concentration Ratio 3.4.1 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Injectable Anticoagulants Revenue in 2020 3.5 Injectable Anticoagulants Key Players Head office and Area Served 3.6 Key Players Injectable Anticoagulants Product Solution and Service 3.7 Date of Enter into Injectable Anticoagulants Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Injectable Anticoagulants Breakdown Data by Type 4.1 Global Injectable Anticoagulants Historic Market Size by Type (2016-2021) 4.2 Global Injectable Anticoagulants Forecasted Market Size by Type (2022-2027) 5 Injectable Anticoagulants Breakdown Data by Application 5.1 Global Injectable Anticoagulants Historic Market Size by Application (2016-2021) 5.2 Global Injectable Anticoagulants Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Injectable Anticoagulants Market Size (2016-2027) 6.2 North America Injectable Anticoagulants Market Size by Type 6.2.1 North America Injectable Anticoagulants Market Size by Type (2016-2021) 6.2.2 North America Injectable Anticoagulants Market Size by Type (2022-2027) 6.2.3 North America Injectable Anticoagulants Market Size by Type (2016-2027) 6.3 North America Injectable Anticoagulants Market Size by Application 6.3.1 North America Injectable Anticoagulants Market Size by Application (2016-2021) 6.3.2 North America Injectable Anticoagulants Market Size by Application (2022-2027) 6.3.3 North America Injectable Anticoagulants Market Size by Application (2016-2027) 6.4 North America Injectable Anticoagulants Market Size by Country 6.4.1 North America Injectable Anticoagulants Market Size by Country (2016-2021) 6.4.2 North America Injectable Anticoagulants Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Injectable Anticoagulants Market Size (2016-2027) 7.2 Europe Injectable Anticoagulants Market Size by Type 7.2.1 Europe Injectable Anticoagulants Market Size by Type (2016-2021) 7.2.2 Europe Injectable Anticoagulants Market Size by Type (2022-2027) 7.2.3 Europe Injectable Anticoagulants Market Size by Type (2016-2027) 7.3 Europe Injectable Anticoagulants Market Size by Application 7.3.1 Europe Injectable Anticoagulants Market Size by Application (2016-2021) 7.3.2 Europe Injectable Anticoagulants Market Size by Application (2022-2027) 7.3.3 Europe Injectable Anticoagulants Market Size by Application (2016-2027) 7.4 Europe Injectable Anticoagulants Market Size by Country 7.4.1 Europe Injectable Anticoagulants Market Size by Country (2016-2021) 7.4.2 Europe Injectable Anticoagulants Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Injectable Anticoagulants Market Size (2016-2027) 8.2 Asia-Pacific Injectable Anticoagulants Market Size by Type 8.2.1 Asia-Pacific Injectable Anticoagulants Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Injectable Anticoagulants Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Injectable Anticoagulants Market Size by Type (2016-2027) 8.3 Asia-Pacific Injectable Anticoagulants Market Size by Application 8.3.1 Asia-Pacific Injectable Anticoagulants Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Injectable Anticoagulants Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Injectable Anticoagulants Market Size by Application (2016-2027) 8.4 Asia-Pacific Injectable Anticoagulants Market Size by Region 8.4.1 Asia-Pacific Injectable Anticoagulants Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Injectable Anticoagulants Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Injectable Anticoagulants Market Size (2016-2027) 9.2 Latin America Injectable Anticoagulants Market Size by Type 9.2.1 Latin America Injectable Anticoagulants Market Size by Type (2016-2021) 9.2.2 Latin America Injectable Anticoagulants Market Size by Type (2022-2027) 9.2.3 Latin America Injectable Anticoagulants Market Size by Type (2016-2027) 9.3 Latin America Injectable Anticoagulants Market Size by Application 9.3.1 Latin America Injectable Anticoagulants Market Size by Application (2016-2021) 9.3.2 Latin America Injectable Anticoagulants Market Size by Application (2022-2027) 9.3.3 Latin America Injectable Anticoagulants Market Size by Application (2016-2027) 9.4 Latin America Injectable Anticoagulants Market Size by Country 9.4.1 Latin America Injectable Anticoagulants Market Size by Country (2016-2021) 9.4.2 Latin America Injectable Anticoagulants Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Injectable Anticoagulants Market Size (2016-2027) 10.2 Middle East & Africa Injectable Anticoagulants Market Size by Type 10.2.1 Middle East & Africa Injectable Anticoagulants Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Injectable Anticoagulants Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Injectable Anticoagulants Market Size by Type (2016-2027) 10.3 Middle East & Africa Injectable Anticoagulants Market Size by Application 10.3.1 Middle East & Africa Injectable Anticoagulants Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Injectable Anticoagulants Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Injectable Anticoagulants Market Size by Application (2016-2027) 10.4 Middle East & Africa Injectable Anticoagulants Market Size by Country 10.4.1 Middle East & Africa Injectable Anticoagulants Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Injectable Anticoagulants Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Injectable Anticoagulants Introduction 11.1.4 Sanofi Revenue in Injectable Anticoagulants Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Genentech (Roche) 11.2.1 Genentech (Roche) Company Details 11.2.2 Genentech (Roche) Business Overview 11.2.3 Genentech (Roche) Injectable Anticoagulants Introduction 11.2.4 Genentech (Roche) Revenue in Injectable Anticoagulants Business (2016-2021) 11.2.5 Genentech (Roche) Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Details 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction 11.3.4 Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2016-2021) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Injectable Anticoagulants Introduction 11.4.4 Pfizer Revenue in Injectable Anticoagulants Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 The Medicines Company 11.5.1 The Medicines Company Company Details 11.5.2 The Medicines Company Business Overview 11.5.3 The Medicines Company Injectable Anticoagulants Introduction 11.5.4 The Medicines Company Revenue in Injectable Anticoagulants Business (2016-2021) 11.5.5 The Medicines Company Recent Development 11.6 Aspen 11.6.1 Aspen Company Details 11.6.2 Aspen Business Overview 11.6.3 Aspen Injectable Anticoagulants Introduction 11.6.4 Aspen Revenue in Injectable Anticoagulants Business (2016-2021) 11.6.5 Aspen Recent Development 11.7 Otsuka 11.7.1 Otsuka Company Details 11.7.2 Otsuka Business Overview 11.7.3 Otsuka Injectable Anticoagulants Introduction 11.7.4 Otsuka Revenue in Injectable Anticoagulants Business (2016-2021) 11.7.5 Otsuka Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Injectable Anticoagulants Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Low-Molecular-Weight Heparin (LMWH) Table 3. Key Players of Direct Thrombin Inhibitor (DTI) Table 4. Key Players of Others Table 5. Global Injectable Anticoagulants Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Injectable Anticoagulants Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Injectable Anticoagulants Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Injectable Anticoagulants Market Share by Regions (2016-2021) Table 9. Global Injectable Anticoagulants Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Injectable Anticoagulants Market Share by Regions (2022-2027) Table 11. Injectable Anticoagulants Market Trends Table 12. Injectable Anticoagulants Market Drivers Table 13. Injectable Anticoagulants Market Challenges Table 14. Injectable Anticoagulants Market Restraints Table 15. Global Injectable Anticoagulants Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Injectable Anticoagulants Market Share by Players (2016-2021) Table 17. Global Top Injectable Anticoagulants Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2020) Table 18. Ranking of Global Top Injectable Anticoagulants Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Injectable Anticoagulants Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Injectable Anticoagulants Product Solution and Service Table 22. Date of Enter into Injectable Anticoagulants Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 25. Global Injectable Anticoagulants Revenue Market Share by Type (2016-2021) Table 26. Global Injectable Anticoagulants Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Injectable Anticoagulants Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Injectable Anticoagulants Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Injectable Anticoagulants Revenue Market Share by Application (2016-2021) Table 30. Global Injectable Anticoagulants Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Injectable Anticoagulants Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 33. North America Injectable Anticoagulants Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Injectable Anticoagulants Market Size by Application (2016-2021) (US$ Million) Table 35. North America Injectable Anticoagulants Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Injectable Anticoagulants Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Injectable Anticoagulants Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Injectable Anticoagulants Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Injectable Anticoagulants Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Injectable Anticoagulants Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Injectable Anticoagulants Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Injectable Anticoagulants Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Injectable Anticoagulants Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Injectable Anticoagulants Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Injectable Anticoagulants Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Injectable Anticoagulants Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Injectable Anticoagulants Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Injectable Anticoagulants Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Injectable Anticoagulants Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Injectable Anticoagulants Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Injectable Anticoagulants Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Injectable Anticoagulants Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Injectable Anticoagulants Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Injectable Anticoagulants Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Injectable Anticoagulants Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Injectable Anticoagulants Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Injectable Anticoagulants Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Injectable Anticoagulants Market Size by Country (2022-2027) & (US$ Million) Table 62. Sanofi Company Details Table 63. Sanofi Business Overview Table 64. Sanofi Injectable Anticoagulants Product Table 65. Sanofi Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 66. Sanofi Recent Development Table 67. Genentech (Roche) Company Details Table 68. Genentech (Roche) Business Overview Table 69. Genentech (Roche) Injectable Anticoagulants Product Table 70. Genentech (Roche) Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 71. Genentech (Roche) Recent Development Table 72. Boehringer Ingelheim Company Details Table 73. Boehringer Ingelheim Business Overview Table 74. Boehringer Ingelheim Injectable Anticoagulants Product Table 75. Boehringer Ingelheim Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 76. Boehringer Ingelheim Recent Development Table 77. Pfizer Company Details Table 78. Pfizer Business Overview Table 79. Pfizer Injectable Anticoagulants Product Table 80. Pfizer Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 81. Pfizer Recent Development Table 82. The Medicines Company Company Details Table 83. The Medicines Company Business Overview Table 84. The Medicines Company Injectable Anticoagulants Product Table 85. The Medicines Company Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 86. The Medicines Company Recent Development Table 87. Aspen Company Details Table 88. Aspen Business Overview Table 89. Aspen Injectable Anticoagulants Product Table 90. Aspen Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 91. Aspen Recent Development Table 92. Otsuka Company Details Table 93. Otsuka Business Overview Table 94. Otsuka Injectable Anticoagulants Product Table 95. Otsuka Revenue in Injectable Anticoagulants Business (2016-2021) & (US$ Million) Table 96. Otsuka Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Injectable Anticoagulants Market Share by Type: 2020 VS 2027 Figure 2. Low-Molecular-Weight Heparin (LMWH) Features Figure 3. Direct Thrombin Inhibitor (DTI) Features Figure 4. Others Features Figure 5. Global Injectable Anticoagulants Market Share by Application: 2020 VS 2027 Figure 6. VTE Case Studies Figure 7. ACS/MI Case Studies Figure 8. AF Case Studies Figure 9. Others Case Studies Figure 10. Injectable Anticoagulants Report Years Considered Figure 11. Global Injectable Anticoagulants Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Injectable Anticoagulants Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Injectable Anticoagulants Market Share by Regions: 2020 VS 2027 Figure 14. Global Injectable Anticoagulants Market Share by Regions (2022-2027) Figure 15. Global Injectable Anticoagulants Market Share by Players in 2020 Figure 16. Global Top Injectable Anticoagulants Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Injectable Anticoagulants Revenue in 2020 Figure 18. Global Injectable Anticoagulants Revenue Market Share by Type (2016-2021) Figure 19. Global Injectable Anticoagulants Revenue Market Share by Type (2022-2027) Figure 20. North America Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Injectable Anticoagulants Market Share by Type (2016-2027) Figure 22. North America Injectable Anticoagulants Market Share by Application (2016-2027) Figure 23. North America Injectable Anticoagulants Market Share by Country (2016-2027) Figure 24. United States Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Injectable Anticoagulants Market Share by Type (2016-2027) Figure 28. Europe Injectable Anticoagulants Market Share by Application (2016-2027) Figure 29. Europe Injectable Anticoagulants Market Share by Country (2016-2027) Figure 30. Germany Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Injectable Anticoagulants Market Share by Type (2016-2027) Figure 38. Asia-Pacific Injectable Anticoagulants Market Share by Application (2016-2027) Figure 39. Asia-Pacific Injectable Anticoagulants Market Share by Region (2016-2027) Figure 40. China Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Injectable Anticoagulants Market Share by Type (2016-2027) Figure 48. Latin America Injectable Anticoagulants Market Share by Application (2016-2027) Figure 49. Latin America Injectable Anticoagulants Market Share by Country (2016-2027) Figure 50. Mexico Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Injectable Anticoagulants Market Share by Type (2016-2027) Figure 54. Middle East & Africa Injectable Anticoagulants Market Share by Application (2016-2027) Figure 55. Middle East & Africa Injectable Anticoagulants Market Share by Country (2016-2027) Figure 56. Turkey Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Injectable Anticoagulants Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Sanofi Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 60. Genentech (Roche) Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 61. Boehringer Ingelheim Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 63. The Medicines Company Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 64. Aspen Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 65. Otsuka Revenue Growth Rate in Injectable Anticoagulants Business (2016-2021) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Sanofi Genentech (Roche) Boehringer Ingelheim Pfizer The Medicines Company Aspen Otsuka